Login / Signup

Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study.

Shinsuke HideseFuyuko YoshidaIkki IshidaJunko MatsuoKotaro HattoriHiroshi Kunugi
Published in: Neuropsychopharmacology reports (2022)
Our data suggest that plasma neuropeptide levels do not elucidate the involvement of neuropeptides in the pathology of schizophrenia, BD, or MDD.
Keyphrases
  • bipolar disorder
  • major depressive disorder
  • high throughput
  • electronic health record
  • sensitive detection
  • deep learning
  • artificial intelligence